Total raised
$4.0M
Last: Seed 2011-05
Stage
Seed
Founded
2010
Headcount
6
HQ
Nazareth
Sector
Health Tech & Life Sciences
About
Metallo-Therapy (MT) is developing contrast agents that enable precise tumor detection and monitoring using CT imaging. MT's proprietary gold nanoparticles (GNP) accumulate in malignant tumors and remain therefor a few weeks. Due to their low toxicity and contrasting function, the GNPs can function as nano-markers, supporting and enhancing multiple applications in the management of cancer patients undergoing radiotherapy. Metallo-Therapy is supported by the Chief Scientist of the Israeli Ministry of Economy and by Arkin Holdings, an investment fund focused on innovative technologies in the healthcare market.
Funding history · 1 round · $4.0M total
2011-05
Seed
$4.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Simulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
imagingradiologyhospitalsdetectioncancermedical-technologiesx-raydiagnostics